Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clemente

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Journal of Cardiovascular Pharmacology|January 5, 2022
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL RegistryAlberto Cordero, M Rosa Fernández Del Olmo, Gustavo A Cortez Quiroga, et al.
Heart (British Cardiac Society)|May 27, 2020
Mutations in <i>TRIM63</i> cause an autosomal-recessive form of hypertrophic cardiomyopathyJoel Salazar-Mendiguchía, Juan Pablo Ochoa, Julian Palomino-Doza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2010
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex developmentL Audi, M Fernández-Cancio, A Carrascosa, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Journal of Cardiovascular Pharmacology|January 5, 2022
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL RegistryAlberto Cordero, M Rosa Fernández Del Olmo, Gustavo A Cortez Quiroga, et al.
Heart (British Cardiac Society)|May 27, 2020
Mutations in <i>TRIM63</i> cause an autosomal-recessive form of hypertrophic cardiomyopathyJoel Salazar-Mendiguchía, Juan Pablo Ochoa, Julian Palomino-Doza, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2010
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex developmentL Audi, M Fernández-Cancio, A Carrascosa, et al.
Pageof 25